As many adults are on a GLP-1 today as had ever tried one a year and a half ago
A meta-analysis of 42,920 participants from five randomized trials demonstrated that GLP-1 RAs are associated with a significant reduction in the risk of the composite cardiovascular disease in patients with diabetes and established ASCVD [53]
Employers appear to be moving in the opposite direction, limiting or ending access, creating annual per-member spending caps, or in the case of Cigna limiting year-over-year price increases
Available from: 58
In addition, the migrating cells were significantly reduced after semaglutide treatment (Figures 12DF), suggesting that semaglutide may be a promising strategy to suppress the progression of CRC
Ways to Access Affordable GLP-1 Treatment For patients seeking GLP-1 treatment, several strategies may help reduce costs or improve access, though options remain limited compared to many other medications